Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43).

by Dennis Schrijnders, Laura C Hartog, Nanne Kleefstra, Klaas H Groenier, Gijs W D Landman, Henk J G Bilo
Published 2016-01-01

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized...

by Johanna Hortensius, Nanne Kleefstra, Gijs W. D. Landman, Bas T. Houweling, Klaas H. Groenier, Jaap J. van der Bijl, Henk Bilo
Published 2018-01-01

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)

by Steven H. Hendriks, Marco H. Blanker, Yvonne Roelofsen, Kornelis J. J. van Hateren, Klaas H. Groenier, Henk J. G. Bilo, Nanne Kleefstra
Published 2018-04-01

Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45).

by Steven H Hendriks, Kornelis J J van Hateren, Klaas H Groenier, Sebastiaan T Houweling, Angela H E M Maas, Nanne Kleefstra, Henk J G Bilo
Published 2015-01-01

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients

by Esther G. Gerrits, Helen L. Lutgers, Gertie H.W. Smeets, Klaas H. Groenier, Andries J. Smit, Reinold O.B. Gans, Henk J.G. Bilo
Published 2012-07-01

Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus

by Peter R. vanDijk, Femke Waanders, Susan J. J. Logtenberg, Klaas H. Groenier, Titia M. Vriesendorp, Nanne Kleefstra, Harry vanGoor, Henk J. G. Bilo
Published 2019-10-01

Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?

by Steven H. Hendriks, Laura C. Hartog, Klaas H. Groenier, Angela H. E. M. Maas, Kornelis J. J. van Hateren, Nanne Kleefstra, Henk J. G. Bilo
Published 2016-01-01

The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13).

by Kornelis J J van Hateren, Gijs W D Landman, Nanne Kleefstra, Susan J J Logtenberg, Klaas H Groenier, Adriaan M Kamper, Sebastiaan T Houweling, Henk J G Bilo
Published 2009-12-01

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)

by Yvonne Roelofsen, Michael van Vugt, Steven H. Hendriks, Kornelis J. J. van Hateren, Klaas H. Groenier, Frank J. Snoek, Nanne Kleefstra, Robbert Huijsman, Henk J. G. Bilo
Published 2016-01-01

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

by Dennis Schrijnders, Geertruida H. de Bock, Sebastiaan T. Houweling, Kornelis J. J. van Hateren, Klaas H. Groenier, Jeffrey A. Johnson, Henk J. G. Bilo, Nanne Kleefstra, Gijs W. D. Landman
Published 2017-06-01

Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy.

by Alaa Alkhalaf, Nanne Kleefstra, Klaas H Groenier, Henk J G Bilo, Reinold O B Gans, Peter Heeringa, Jean L Scheijen, Casper G Schalkwijk, Gerjan J Navis, Stephan J L Bakker
Published 2012-01-01

Comparison of methods for renal risk prediction in patients with type 2 diabetes (ZODIAC-36).

by Ineke J Riphagen, Nanne Kleefstra, Iefke Drion, Alaa Alkhalaf, Merel van Diepen, Qi Cao, Klaas H Groenier, Gijs W D Landman, Gerjan Navis, Henk J G Bilo, Stephan J L Bakker
Published 2015-01-01

Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials.

by Gijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, Peter R van Dijk, Klaas H Groenier, Rijk O B Gans, Sebastiaan T Houweling, Henk J G Bilo, Nanne Kleefstra
Published 2014-01-01

Lifestyle and emotional well-being in men and women with type 2 diabetes (e-VitaDM-4; ZODIAC-48)

by Steven H. Hendriks, Evelien G.W. van Soldt, Michael van Vugt, Klaas H. Groenier, Yvonne Roelofsen, Angela H. E. M. Maas, Henk J. G. Bilo, Nanne Kleefstra, Kornelis J. J. van Hateren
Published 2017-10-01

Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study

by Jing de Haan-Du, Gijs W. D. Landman, Nanne Kleefstra, Dennis Schrijnders, Marjolijn Manders, Amanda C. R. K. Bos, Cathrien Tromp-van Driel, Petra Denig, Klaas H. Groenier, Geertruida H. de Bock
Published 2021-06-01

Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes

by Peter R. van Dijk, Femke Waanders, Andreas Pasch, Susan J. J. Logtenberg, Titia Vriesendorp, Klaas H. Groenier, Jan-Luuk Hillebrands, Nanno Kleefstra, Rijk O. B. Gans, Harry van Goor, Henk J.G. Bilo
Published 2020-03-01

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32).

by Kornelis J J van Hateren, Gijs W D Landman, Jarinke F H Arnold, Hanneke Joosten, Klaas H Groenier, Gerjan J Navis, Andrea Sparwasser, Stephan J L Bakker, Henk J G Bilo, Nanne Kleefstra
Published 2015-01-01

Serum free thiols in type 2 diabetes mellitus: A prospective study

by Emmelien E.M. Schillern, Andreas Pasch, Martin Feelisch, Femke Waanders, Steven H. Hendriks, Rik Mencke, Geert Harms, Klaas H. Groenier, Henk J.G. Bilo, Jan-Luuk Hillebrands, Harry van Goor, Peter R. van Dijk
Published 2019-06-01

Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).

by Esther G Gerrits, Alaa Alkhalaf, Gijs W D Landman, Kornelis J J van Hateren, Klaas H Groenier, Joachim Struck, Janin Schulte, Reinold O B Gans, Stephan J L Bakker, Nanne Kleefstra, Henk J G Bilo
Published 2014-01-01